Private Equity

Private Equity Law360 provides breaking news and analysis on private equity deals and the attorneys involved. Coverage includes high-impact deals, related litigation and enforcement actions, and policy developments that affect private equity firms.



Sign up for a 7-day FREE trial today!



Latest News in Private Equity

  • May 01, 2026

    Biotech IPOs Surge Ahead As 2 Listings Raise $557M

    A pair of biotechnology firms began trading on Friday after raising a combined $557 million through upsized initial public offerings that both priced at the top of their proposed $16 to $18 ranges, marking the latest drug developers to join the IPO market in recent weeks.

  • May 01, 2026

    Calif. Case Raises Questions For Medical Practice Investors

    The California attorney general's amicus brief in Art Center v. WCE and the California Medical Association's response highlight how the California appeals court's ruling could significantly affect the structure and enforceability of succession arrangements in medical practice ownership, say attorneys at Ropes & Gray.

  • May 01, 2026

    Steel Firm Workers Get OK For $1.8M ESOP Deal, $600K Fee

    A Michigan federal judge has approved a $1.8 million class settlement resolving claims that trustees of a steel company employee stock ownership plan overpaid for company stock, finding the deal "fair, reasonable and adequate" and in the best interest of plan participants. 

  • May 01, 2026

    Feds Say RealPage Deal Fixes Rental Pricing Concerns

    The government has told a North Carolina federal court its settlement with RealPage fully resolves issues regarding landlords using the company's software to inflate rental rates, despite criticism from a pro-enforcement group.

  • May 01, 2026

    Sidley, Goodwin Lead $1.1B Take-Private Deal For Esperion

    Biopharmaceutical company Esperion Therapeutics, advised by Goodwin Procter LLP, on Friday announced plans to go private after being bought by Sidley Austin LLP-led healthcare-focused investment firm Archimed in a $1.1 billion deal.

See more Private Equity news

Private Equity

Areas of Coverage

  • TRANSACTIONS
  • Private equity deals valued at $50MM or more
  • Venture capital investments of $25MM or more
  • Mergers and acquisitions
  • Capital investments, including mezzanine and growth capital deals
  • Joint ventures involving private equity firms
  • Hostile takeovers and leveraged buyouts
  • Distressed investment deals
  • AGENCIES
  • U.S. Commodity Futures Trading Commission
  • Federal Trade Commission
  • Financial Industry Regulatory Authority
  • Public Company Accounting Oversight Board
  • U.S. Department of Justice
  • U.S. Department of the Treasury
  • U.S. Securities and Exchange Commission
  • International competition and securities regulators
  • POLICY & REGULATION
  • Dodd-Frank Act
  • Delaware corporate law
  • Antitrust and consumer protection controls
  • Private equity industry lobbying
  • International banking legislation and regulation
  • ENFORCEMENT
  • Merger reviews
  • Second requests
  • Challenges and divestitures
  • Litigation
  • Antitrust suits
  • Shareholder disputes
  • Corporate governance fights
  • Poison pill challenges
  • Hostile takeover disputes
  • Privacy and consumer protection suits
  • Bankruptcy proceedings involving private equity stakeholders
  • PROFILES
  • Personnel moves
  • Profiles of private equity practices

Readership

  • Private equity lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the private equity industry
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals